Flagship Ventures Fund V General Partner LLC
Related Filers (26)
- Flagship Ventures Fund V, L.P. (22)
- AFEYAN NOUBAR (20)
- Flagship Pioneering Inc. (13)
- Flagship V VentureLabs Rx Fund, L.P. (12)
- Flagship VentureLabs V LLC (10)
- Flagship VentureLabs V Manager LLC (8)
- Flagship Ventures Opportunities Fund I, L.P. (7)
- Flagship Ventures Opportunities Fund I General Partner LLC (7)
- Sana Biotechnology, Inc. (5)
- Flagship Pioneering Special Opportunities Fund II General Partner LLC (5)
- Flagship Pioneering Special Opportunities Fund II, L.P. (5)
- Nutritional Health Side Fund, L.P. (4)
- Nutritional Health Disruptive Innovation Fund, L.P. (4)
- Codiak BioSciences, Inc. (3)
- Sigilon Therapeutics, Inc. (3)
- Flagship Pioneering Fund VI General Partner LLC (3)
- Flagship Pioneering Fund VI, L.P. (3)
- Denali Therapeutics Inc. (2)
- Evelo Biosciences, Inc. (2)
- KANIA EDWIN M JR (2)
- Kaleido Biosciences, Inc. (2)
- Foghorn Therapeutics Inc. (2)
- Omega Therapeutics, Inc. (2)
- Rubius Therapeutics, Inc. (1)
- Flagship Ventures Fund IV, L.P. (1)
- Flagship Ventures Fund IV General Partner LLC (1)
- Show More ...
Other (25)
13F-NT
Wednesday, 2/14/2024
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 11/14/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 8/14/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 5/15/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 2/14/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 11/14/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 8/15/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 5/16/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 2/14/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 11/15/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 8/16/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 5/17/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 2/16/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 11/16/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Thursday, 8/13/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Thursday, 5/14/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Thursday, 2/13/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Thursday, 11/14/2019
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 8/13/2019
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 5/14/2019
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Wednesday, 2/13/2019
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 11/13/2018
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 8/7/2018
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 5/15/2018
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Wednesday, 2/14/2018
Initial Quarterly Form 13F Notice Report filed by institutional managers
Ownership (22)
4
Friday, 9/15/2023
Sana Biotechnology, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/15/2023
Sigilon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/8/2023
Sana Biotechnology, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/26/2023
Sana Biotechnology, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/16/2022
Codiak BioSciences, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 8/5/2021
Omega Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/29/2021
Omega Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 3/23/2021
Rubius Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/10/2021
Sana Biotechnology, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 2/3/2021
Sana Biotechnology, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 12/10/2020
Sigilon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 12/3/2020
Sigilon Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 10/29/2020
Foghorn Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/22/2020
Foghorn Therapeutics Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 10/20/2020
Codiak BioSciences, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 10/13/2020
Codiak BioSciences, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 3/6/2019
Kaleido Biosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 2/27/2019
Kaleido Biosciences, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 5/15/2018
Evelo Biosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 5/8/2018
Evelo Biosciences, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 12/12/2017
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 12/7/2017
Denali Therapeutics Inc.: Initial statement of beneficial ownership of securities